Clinical Trial Update: Pilot Study of FFP104 Dose Escalation in PBC Subjects [Phase 1, Phase 2]

View source ↗

Summary

Pilot dose-escalation study of FFP104 in subjects with Primary Biliary Cholangitis (Phase 1/Phase 2) with current status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• FFP104

Snippet

Sponsor: Fast Forward Pharmaceuticals | Conditions: Primary Biliary Cirrhosis | Phase 1, Phase 2 | Status: UNKNOWN